Wordt geladen...
Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance
Clinical antimicrobial susceptibility breakpoints are used to predict the clinical outcome of antimicrobial treatment. In contrast, microbiologic breakpoints are used to identify isolates that may be categorized as susceptible when applying clinical breakpoints but harbor resistance mechanisms that...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Centers for Disease Control and Prevention
2003
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3023429/ https://ncbi.nlm.nih.gov/pubmed/12890324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid0907.020589 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|